Sila Realty Trust, Inc. (SILA) Stock Analysis and Metrics

Sila Realty Trust

$30.36 ▲ +0.00 (+0.00%)

At close: Jun 30, 2026 · 4:00 PM UTC

Financial Ratios

Market Cap1.88 Bn

P/E-10.23

P/S9.33

Div. Yield0.05

Total Debt (Qtr)688.44 Mn

Add ratio to table…

About

Sila Realty Trust, Inc. is an internally managed real estate investment trust that focuses on acquiring high quality healthcare facilities across the continuum of care. The company was formed in 2013 and elected to be taxed as a REIT under the Internal Revenue Code. As of December 31, 2024, it owned 135 real estate healthcare properties and two undeveloped land parcels. Its portfolio includes inpatient rehabilitation centers, behavioral health facilities, skilled nursing properties, and other care sites. Sila Realty Trust may also make equity or debt investments in other real estate entities when opportunities align with its strategy. The company seeks to acquire properties that are essential to the daily operations of its tenants and are located in markets with strong demographic trends. Sila Realty Trust employs an internal team to manage acquisitions, asset management, and disposition activities. As a REIT, it must distribute at least 90% of its taxable income to shareholders to maintain its tax status.

The company generates revenue primarily from rental income collected on its properties under long term net leased agreements. These leases typically include annual or periodic rent increases and are structured to pass operating expenses to the tenant. In addition to rent, Sila Realty Trust earns interest income from mezzanine loans it has originated for the development of healthcare projects. The mezzanine loans originated in 2024 have committed amounts of twelve million five hundred forty three thousand dollars and five million dollars respectively. These loans are scheduled to mature in November 2029 and funding is expected to begin in 2025. Property sales during the year generated gross proceeds of eighteen million seven hundred thousand dollars and net proceeds of seventeen million seven hundred five thousand dollars. The company may also realize gains from the occasional sale of properties that no longer meet its investment criteria. Interest income from cash balances and other investments contributes a smaller share of total revenue. The company also earns modest income from interest on cash balances, short term investments, and other liquid assets.

Sila Realty Trust operates in a competitive healthcare real estate market where it faces rivals such as other public REITs, private equity funds, and institutional investors that pursue similar assets. Its competitive advantages stem from an internally managed structure that reduces reliance on external advisors, a focus on creditworthy tenants that often carry investment grade ratings, and a lease strategy that emphasizes long term contracts with built in rent escalations. The company also seeks geographic and tenant diversification to reduce exposure to any single market or operator. These factors help Sila Realty Trust maintain stable cash flows and support its goal of delivering regular distributions to shareholders. It also monitors tenant credit through review of publicly available financial statements, industry reports, and rent collection timeliness. The management team believes that its focus on long term net leased structures reduces turnover and enhances predictability of cash flows.

The company's tenants are healthcare operators that range from large national chains to regional and local providers. As of December 31, 2024, the largest single tenant was Post Acute Medical, LLC and its affiliates, which contributed approximately 14.9% of rental revenue for the year. Other important tenants include skilled nursing firms, rehabilitation centers, and behavioral health service providers. Sila Realty Trust does not disclose a full list of tenant names beyond the major concentration noted, but its portfolio is designed to serve facilities that provide essential care to patients across the United States. The portfolio includes properties leased to operators of inpatient rehabilitation, behavioral health, and skilled nursing facilities across multiple states. No other single tenant accounted for 10% or more of rental revenue in 2024 besides the Post Acute Medical group.

Investment Thesis

▲ Bull case

Sila Realty Trust's recent Q1 2026 performance demonstrates underlying operational strength that is not fully reflected in current market valuations, particularly as the company's Cash NOI grew 12.4% year-over-year to $46.3 million driven by accretive acquisitions and redevelopment initiatives, while same-store Cash NOI increased 0.7% despite disposal-related headwinds, indicating core portfolio resilience. The company's strategic capital deployment—evidenced by the $43.3 million acquisition of the Oklahoma City Healthcare Facility X with a 2046 lease expiry—continues to enhance long-term income visibility, especially given management's consistent focus on assets yielding 150-200 basis points above recent acquisition cap rates through targeted redevelopment, such as the ongoing investments at Dover and Overland Park facilities with PAM Health, which represent the company's largest and highest-quality tenant relationship. These internal growth opportunities, combined with a weighted average lease term of 10.1 years and 98.7% occupancy as of March 31, 2026, create a predictable cash flow foundation that supports sustainable AFFO growth, which rose 14.0% year-over-year to $0.61 per diluted share in Q1 2026, outperforming the prior year's decline and signaling a turning point in earnings quality that the market may be overlooking amid broader REIT sector volatility.
The pending merger with Blue Owl Real Estate Capital at $30.38 per share—a 19% premium to the pre-announcement price—reveals a significant valuation disconnect between Sila's intrinsic asset value and its public market trading range, particularly as the deal implies an implied cap rate in the mid-5% range for the portfolio, well below the 7%+ going-in cap rates management cited for comparable healthcare assets during the Q4 2025 earnings call, suggesting the market has been applying an excessive discount to Sila's triple-net leased, investment-grade tenant base. This premium is further justified by Sila's improving tenant credit quality, with investment-grade sponsors now representing 40.6% of annual base rent—a 2.3 percentage point increase year-over-year—and recent sponsorship upgrades like the Washington Regional Medical Center lease at Fayetteville and Select Medical's bankruptcy-driven takeover of the Savannah asset, which collectively reduce concentration risk and enhance lease durability, yet these fundamental improvements have not been fully priced into the stock ahead of the transaction close, creating a clear arbitrage opportunity for investors who recognize the company's de-risked, growing cash flow profile.
Sila's balance sheet flexibility remains a materially underappreciated catalyst, with over $435 million of undrawn capacity under its unsecured credit facilities and liquidity exceeding $465 million as of March 31, 2026, enabling the company to pursue accretive acquisitions or internal redeployments without immediate equity dilution, especially as net debt to EBITDAre stood at a conservative 3.9x—well below the targeted 4.5x-5.5x range—providing up to $375 million of additional debt capacity if leverage were increased to the high end of its target range, a point management explicitly noted during the Q4 2025 call when discussing 24 months of deployable buying power; this financial headroom, combined with the company's disciplined capital allocation history and focus on high-yielding opportunities within its existing portfolio (such as the El Segundo facility's deferred rent proceeds from UCLA-related development costs), positions Sila to generate incremental AFFO growth through internal initiatives that require minimal execution risk, a factor that could drive multiple expansion even in a stagnant acquisition market if the Blue Owl deal were to fail, though the merger's strong premium and strategic rationale make such an outcome increasingly unlikely.

Sila Realty Trust's recent Q1 2026 performance demonstrates underlying operational strength that is not fully reflected in current market valuations, particularly as the company's Cash NOI grew 12.4% year-over-year to $46.3 million driven by accretive acquisitions and redevelopment initiatives, while same-store Cash NOI increased 0.7% despite disposal-related headwinds, indicating core portfolio resilience. The company's strategic capital deployment—evidenced by the $43.3 million acquisition of the Oklahoma City Healthcare Facility X with a 2046 lease expiry—continues to enhance long-term income visibility, especially given management's consistent focus on assets yielding 150-200 basis points above recent acquisition cap rates through targeted redevelopment, such as the ongoing investments at Dover and Overland Park facilities with PAM Health, which represent the company's largest and highest-quality tenant relationship. These internal growth opportunities, combined with a weighted average lease term of 10.1 years and 98.7% occupancy as of March 31, 2026, create a predictable cash flow foundation that supports sustainable AFFO growth, which rose 14.0% year-over-year to $0.61 per diluted share in Q1 2026, outperforming the prior year's decline and signaling a turning point in earnings quality that the market may be overlooking amid broader REIT sector volatility.
The pending merger with Blue Owl Real Estate Capital at $30.38 per share—a 19% premium to the pre-announcement price—reveals a significant valuation disconnect between Sila's intrinsic asset value and its public market trading range, particularly as the deal implies an implied cap rate in the mid-5% range for the portfolio, well below the 7%+ going-in cap rates management cited for comparable healthcare assets during the Q4 2025 earnings call, suggesting the market has been applying an excessive discount to Sila's triple-net leased, investment-grade tenant base. This premium is further justified by Sila's improving tenant credit quality, with investment-grade sponsors now representing 40.6% of annual base rent—a 2.3 percentage point increase year-over-year—and recent sponsorship upgrades like the Washington Regional Medical Center lease at Fayetteville and Select Medical's bankruptcy-driven takeover of the Savannah asset, which collectively reduce concentration risk and enhance lease durability, yet these fundamental improvements have not been fully priced into the stock ahead of the transaction close, creating a clear arbitrage opportunity for investors who recognize the company's de-risked, growing cash flow profile.
Sila's balance sheet flexibility remains a materially underappreciated catalyst, with over $435 million of undrawn capacity under its unsecured credit facilities and liquidity exceeding $465 million as of March 31, 2026, enabling the company to pursue accretive acquisitions or internal redeployments without immediate equity dilution, especially as net debt to EBITDAre stood at a conservative 3.9x—well below the targeted 4.5x-5.5x range—providing up to $375 million of additional debt capacity if leverage were increased to the high end of its target range, a point management explicitly noted during the Q4 2025 call when discussing 24 months of deployable buying power; this financial headroom, combined with the company's disciplined capital allocation history and focus on high-yielding opportunities within its existing portfolio (such as the El Segundo facility's deferred rent proceeds from UCLA-related development costs), positions Sila to generate incremental AFFO growth through internal initiatives that require minimal execution risk, a factor that could drive multiple expansion even in a stagnant acquisition market if the Blue Owl deal were to fail, though the merger's strong premium and strategic rationale make such an outcome increasingly unlikely.

▼ Bear case

Sila Realty Trust faces significant near-term execution risk stemming from the pending merger with Blue Owl Real Estate Capital, as the transaction's completion remains contingent on stockholder approval and regulatory clearance, with the company's own forward-looking statements in the Q1 2026 earnings release explicitly citing risks such as unanticipated difficulties in retaining key personnel, tenant and business partner pushback, and potential difficulties in employee retention due to the announcement and pendency of the Merger Agreement—factors that could disrupt operational continuity at properties like the El Segundo Healthcare Facility, where deferred rent proceeds tied to UCLA's development costs are recognized over time and represent a material portion of Q1 2026 Cash NOI growth, and any deterioration in tenant relations or operational stability during the integration process could undermine the very predictable income streams that form the core of Sila's investment thesis, particularly given management's acknowledgment that the real assets division of Blue Owl has faced significant stock price declines and investor skepticism over its growth prospects, raising concerns about the acquirer's long-term commitment to maintaining Sila's current operational model post-close.
The company's reliance on external growth through acquisitions is increasingly challenged by a widening spread between Sila's current trading valuation and the actual market pricing for comparable healthcare assets, as management indicated during the Q4 2025 call that go-in cap rates for similar facilities generally range from the high 6s to mid-7s (6.5%-7.5%), while Sila's implied cap rate based on its Q1 2026 AFFO of $0.61 per share and current share price (~$25.50 pre-merger announcement) exceeds 8%, suggesting the market is applying a substantial discount to the REIT's cash flows that may not be justified by fundamentals alone but instead reflects persistent investor healthcare REIT sector aversion, rising interest rate sensitivity, or concerns about long-term demand shifts in outpatient care—especially given the silver tsunami narrative's dependence on continued operator profitability, which could be pressured by labor shortages, reimbursement rate compression, or increasing acuity costs that may not be fully passed through under triple-net lease structures, thereby threatening the durability of Sila's income streams despite its current high EBITDARM coverage of 5.9x.
Sila's AFFO performance remains structurally fragile, as evidenced by the 5.8% year-over-year decline in full-year 2025 AFFO per share to $2.18 despite a 3.6% increase in FFO per share, a divergence primarily driven by elevated interest expense from new swaps entered into in 2024 following prior swap maturities—a trend that could persist or worsen if the Federal Reserve maintains higher-for-longer interest rates, directly impacting the company's sensitivity to rate fluctuations given its $690 million in outstanding principal debt as of March 31, 2026, with a weighted average interest rate of 4.7%, and while management highlighted reduced G&A and lower personnel costs as partial offsets, the fact that AFFO—often viewed as a more accurate proxy for sustainable dividend-paying capacity—declined while FFO rose suggests underlying cost pressures or one-time benefits are masking weaker organic earnings power, a concern amplified by the company's dependence on straight-line rent adjustments and interest income from mezzanine loans to bolster FFO, which may not be replicable at scale, and the potential for AFFO to remain under pressure if acquisition yields fail to meaningfully exceed the company's current cost of debt, limiting the accretive impact of future portfolio expansion.

Sila Realty Trust faces significant near-term execution risk stemming from the pending merger with Blue Owl Real Estate Capital, as the transaction's completion remains contingent on stockholder approval and regulatory clearance, with the company's own forward-looking statements in the Q1 2026 earnings release explicitly citing risks such as unanticipated difficulties in retaining key personnel, tenant and business partner pushback, and potential difficulties in employee retention due to the announcement and pendency of the Merger Agreement—factors that could disrupt operational continuity at properties like the El Segundo Healthcare Facility, where deferred rent proceeds tied to UCLA's development costs are recognized over time and represent a material portion of Q1 2026 Cash NOI growth, and any deterioration in tenant relations or operational stability during the integration process could undermine the very predictable income streams that form the core of Sila's investment thesis, particularly given management's acknowledgment that the real assets division of Blue Owl has faced significant stock price declines and investor skepticism over its growth prospects, raising concerns about the acquirer's long-term commitment to maintaining Sila's current operational model post-close.
The company's reliance on external growth through acquisitions is increasingly challenged by a widening spread between Sila's current trading valuation and the actual market pricing for comparable healthcare assets, as management indicated during the Q4 2025 call that go-in cap rates for similar facilities generally range from the high 6s to mid-7s (6.5%-7.5%), while Sila's implied cap rate based on its Q1 2026 AFFO of $0.61 per share and current share price (~$25.50 pre-merger announcement) exceeds 8%, suggesting the market is applying a substantial discount to the REIT's cash flows that may not be justified by fundamentals alone but instead reflects persistent investor healthcare REIT sector aversion, rising interest rate sensitivity, or concerns about long-term demand shifts in outpatient care—especially given the silver tsunami narrative's dependence on continued operator profitability, which could be pressured by labor shortages, reimbursement rate compression, or increasing acuity costs that may not be fully passed through under triple-net lease structures, thereby threatening the durability of Sila's income streams despite its current high EBITDARM coverage of 5.9x.
Sila's AFFO performance remains structurally fragile, as evidenced by the 5.8% year-over-year decline in full-year 2025 AFFO per share to $2.18 despite a 3.6% increase in FFO per share, a divergence primarily driven by elevated interest expense from new swaps entered into in 2024 following prior swap maturities—a trend that could persist or worsen if the Federal Reserve maintains higher-for-longer interest rates, directly impacting the company's sensitivity to rate fluctuations given its $690 million in outstanding principal debt as of March 31, 2026, with a weighted average interest rate of 4.7%, and while management highlighted reduced G&A and lower personnel costs as partial offsets, the fact that AFFO—often viewed as a more accurate proxy for sustainable dividend-paying capacity—declined while FFO rose suggests underlying cost pressures or one-time benefits are masking weaker organic earnings power, a concern amplified by the company's dependence on straight-line rent adjustments and interest income from mezzanine loans to bolster FFO, which may not be replicable at scale, and the potential for AFFO to remain under pressure if acquisition yields fail to meaningfully exceed the company's current cost of debt, limiting the accretive impact of future portfolio expansion.

Peer Comparison

Companies in the REIT - Healthcare Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	WELL	Welltower Inc.	172.91 Bn	122.84	12.78	17.93 Bn
2	VTR	Ventas, Inc.	46.62 Bn	179.03	7.60	-
3	DOC	Healthpeak Properties, Inc.	15.34 Bn	69.22	-33.80	0.25 Bn
4	OHI	Omega Healthcare Investors Inc	15.14 Bn	23.22	12.25	0.43 Bn
5	AHR	American Healthcare REIT, Inc.	10.71 Bn	194.58	4.76	1.51 Bn
6	CTRE	CareTrust REIT, Inc.	9.45 Bn	28.24	199.40	0.50 Bn
7	HR	Healthcare Realty Trust Inc	7.33 Bn	-	5.04	4.10 Bn
8	SBRA	Sabra Health Care REIT, Inc.	5.09 Bn	36.93	17.13	0.04 Bn

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password